Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

Experimental and Molecular Medicine

Volumn 34, Issue 4, 2002, Pages 273-277

  Yoo, Young Do ^a   Chung, Young Min ^a   Park, Jong Kuk ^b   Ahn, Chul Min ^c   Kim, Sung Kyu ^c   Kim, Hyung Jung ^c  

^a Korea University College of Medicine   (South Korea)

^b Sogang University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Antisense; Chemosensitizer; Cisplatin; Multidrug resistance; Prx II

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; HYDROGEN PEROXIDE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OXIDATIVE STRESS; PLASMID; RADIOSENSITIVITY; STOMACH CANCER;

EID: 0037201471     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.38     Document Type: Article

References (19)

1. Butterfield LH, Merino A, Golb SH, Shau H. From cytoprotection to tumor suppression: The multifactorial role of peroxiredoxins. Antiox Redox Signal 1999;1:385-402
2. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994;269:27670-8
3. Chae HZ, Kang SW, Rhee SG. Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 1999;300:219-6
4. Chae HZ, Kim HJ, Kang SW, Rhee SG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 1999;45:101-2
5. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH, Yoo YJ. Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 2001;289:507-12
6. Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 2001;21:1129-34
7. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian Peroxiredoxin Isoforms Can Reduce Hydrogen Peroxide Generated in Response to Growth Factors and Tumor Necrosis Factor-α. J Biol Chem 1998;273:6297-302
8. Kim AT, Sarafian TA, Shau H. Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide. Toxicol Appl Pharmacol 1997;147:135-42
9. Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, Kwon OY, Kim YK, Ro HK, Shong M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000;275:18266-70
10. Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res 2001;61:3894-901
11. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer: Anticancer Res 2001;21:2085-90
12. Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, Yoo YD. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 2000;6:4915-20
13. Sato N, Iwata S, Nakamura K, Hori T, Mori K, Yodoi J. Thiolmediated redox regulation of apoptosis. Possible role of cellular thiols other than glutathione in T cell apoptosis. J Immunol 1995;154:3194-203
14. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998;55:1747-58
15. -) by murine macrophages in vitro after cis-platin treatment. Int J Immunopharmacol 1986;8:709-14
16. Spitz DR, Phillips JW, Adams DT, Sherman CM, Deen DF, Li GC. Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: The significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol 1993;156:72-9
17. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett 1999;145:127-32
18. Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H, Yoshida H. Peroxiredoxin I expression in oral cancer: A potential new tumor marker. Cancer Lett 2000;156:27-35
19. Zhang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 1997;272:30615-8